Pennsylvania Psychostimulant Symposium 2019
The Pennsylvania Department of Drug and Alcohol Programs, in coordination with the Mid-Atlantic High-Intensity Drug Trafficking Area program, is convening the Pennsylvania Psychostimulant Symposium on November 19, 2019, at the Best Western Premier in Harrisburg.
While efforts have been focused on quelling the opioid epidemic in Pennsylvania and at the national level, alarming trends have emerged related to the supply and use of prescription and illicit psychostimulants. There are many differences between opioid use disorder (OUD) and methamphetamine or cocaine use disorder. The effectiveness of naloxone varies as well, requiring knowledge of various methods of treatment and handling of overdose victims.
Participants will learn the dangers associated with the misuse of psychostimulants while discovering collaborative strategies for protecting communities and preventing widespread stimulant use disorder.
This full-day Symposium will bring together professionals from diverse backgrounds – ranging from criminal justice to emergency response and health care as well as many other stakeholders for a day of learning, networking, and collaboration. The plenary sessions feature nationally recognized presenters focusing on multiple aspects of stimulant use disorder. Dual breakout sessions will provide participants with the opportunity to prioritize the most relevant training opportunities. Each breakout will have panelists with opportunities for peer-to-peer learning through panel discussions and questions. Exhibits will provide additional resources for participants.
Law enforcement, criminal justice, health care providers, emergency medical services personnel, drug and alcohol prevention and treatment providers, Single County Authorities (SCAs), government officials, public health professionals, and other stakeholders.
Attendance is free, but registration is required. Registration will open in early October. Additional details will be posted as they become available.